Clinical Trial Update: To Evaluate the Effect of Ginkgo Biloba Extract on Optic Nerve Head Perfusion Examined Using OCTA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether Ginkgo Biloba Extract affects optic nerve head perfusion in glaucoma, assessed by OCT angiography, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Glaucoma | Phase 4 | Status: COMPLETED